EHDEN’s scientific contribution to the OHDSI Global Symposium, 14-15th September 2021

The annual OHDSI Global Symposium is a key focal point for observational research internationally, especially within the research framework using the OMOP common data model. This  year marks the seventh edition and sees approximately 1,500 participants joining via the virtual Gather Town platform from all over the world.

Across the Symposium agenda of plenaries and collaborator showcases, broken out in the latter on sessions related to advances in Data Standards, Methods Research, Clinical Operations, and Open-Source Development and Community, EHDEN and its collaborators have 28 presentations.

As well as plenary and lightning talks on EHDEN and OHDSI Europe, what our researcher colleagues are presenting covers a remarkably diverse subject matter, with some highlights below:

  • Establishing a large COVID-19 cohort through mapping the Information System for Research in Primary Care (SIDIAP) in Catalonia to the OMOP Common Data Model
  • Attention based deep neural networks in patient level prediction
  • Treatment Patterns: An R package to analyse treatment patterns of a study population of interest
  • Treatment heterogeneity in comparative effectiveness of teriparatide vs bisphosphonates: multi-database cohort study
  • Comparing the impact of alternative phenotype definitions: insights from developing cohorts for COVID-19 adverse events of special interest
  • Association Rule and Frequent Pattern Mining using the OMOP CDM
  • Long term outcomes of prostate cancer patients managed by watchful waiting: results from the PIONEER/EHDEN/OHDSI study-a-thon

All presentations will become available via following the Symposium.

“We are delighted that EHDEN is  contributing so widely and with such a number of presentations, posters and demonstrations within the OHDSI community this year.  This effort speaks to the commitment of so many colleagues who come together to spread knowledge and foster an open science environment,” said Prof Dani Prieto Alhambra, Research Coordinator, EHDEN, Professor Pharmaco and Device Epidemiology, University of Oxford.